These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 32989677)

  • 41. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.
    Costela-Ruiz VJ; Illescas-Montes R; Puerta-Puerta JM; Ruiz C; Melguizo-Rodríguez L
    Cytokine Growth Factor Rev; 2020 Aug; 54():62-75. PubMed ID: 32513566
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity.
    Huang G; Kovalic AJ; Graber CJ
    Emerg Infect Dis; 2020 Aug; 26(8):1839-1841. PubMed ID: 32384045
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation between immune response and self-reported depression during convalescence from COVID-19.
    Yuan B; Li W; Liu H; Cai X; Song S; Zhao J; Hu X; Li Z; Chen Y; Zhang K; Liu Z; Peng J; Wang C; Wang J; An Y
    Brain Behav Immun; 2020 Aug; 88():39-43. PubMed ID: 32464158
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19.
    Gao Y; Li T; Han M; Li X; Wu D; Xu Y; Zhu Y; Liu Y; Wang X; Wang L
    J Med Virol; 2020 Jul; 92(7):791-796. PubMed ID: 32181911
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.
    Liu J; Liu Y; Xiang P; Pu L; Xiong H; Li C; Zhang M; Tan J; Xu Y; Song R; Song M; Wang L; Zhang W; Han B; Yang L; Wang X; Zhou G; Zhang T; Li B; Wang Y; Chen Z; Wang X
    J Transl Med; 2020 May; 18(1):206. PubMed ID: 32434518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical laboratory parameters associated with severe or critical novel coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
    Moutchia J; Pokharel P; Kerri A; McGaw K; Uchai S; Nji M; Goodman M
    PLoS One; 2020; 15(10):e0239802. PubMed ID: 33002041
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical characteristics and the risk factors for severe events of elderly coronavirus disease 2019 patients.
    Wang G; Wu C; Zhang Q; Yu B; LÜ J; Zhang S; Wu G; Wu Y; Zhong Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):542-548. PubMed ID: 32879104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
    Wang F; Hou H; Luo Y; Tang G; Wu S; Huang M; Liu W; Zhu Y; Lin Q; Mao L; Fang M; Zhang H; Sun Z
    JCI Insight; 2020 May; 5(10):. PubMed ID: 32324595
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Wei J; Zhao J; Han M; Meng F; Zhou J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients.
    Shcherbak SG; Anisenkova AY; Mosenko SV; Glotov OS; Chernov AN; Apalko SV; Urazov SP; Garbuzov EY; Khobotnikov DN; Klitsenko OA; Minina EM; Asaulenko ZP
    Front Immunol; 2021; 12():745515. PubMed ID: 34858403
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical characteristics of coronavirus disease 2019 in Gansu province, China.
    Yue H; Bai X; Wang J; Yu Q; Liu W; Pu J; Wang X; Hu J; Xu D; Li X; Kang N; Li L; Lu W; Feng T; Ding L; Li X; Qi X;
    Ann Palliat Med; 2020 Jul; 9(4):1404-1412. PubMed ID: 32692208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical features in 52 patients with COVID-19 who have increased leukocyte count: a retrospective analysis.
    Zhao K; Li R; Wu X; Zhao Y; Wang T; Zheng Z; Zeng S; Ding X; Nie H
    Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2279-2287. PubMed ID: 32651736
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Neutrophil to lymphocyte ratio as a prognostic marker in COVID-19].
    Basbus L; Lapidus MI; Martingano I; Puga MC; Pollán J
    Medicina (B Aires); 2020; 80 Suppl 3():31-36. PubMed ID: 32658845
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical characteristics and survival analysis in critical and non-critical patients with COVID-19 in Wuhan, China: a single-center retrospective case control study.
    Tian R; Wu W; Wang C; Pang H; Zhang Z; Xu H; Luo Q; Gao P; Shi J; Li W; Qian H; Guo F; Li T; Liu Z; Wang J; Zhou X; Qin Y; Yan X; Zhang S
    Sci Rep; 2020 Oct; 10(1):17524. PubMed ID: 33067568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study.
    Moreno-Pérez O; Andres M; Leon-Ramirez JM; Sánchez-Payá J; Rodríguez JC; Sánchez R; García-Sevila R; Boix V; Gil J; Merino E
    J Autoimmun; 2020 Nov; 114():102523. PubMed ID: 32690352
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.
    Mahmoudi S; Rezaei M; Mansouri N; Marjani M; Mansouri D
    J Clin Immunol; 2020 Oct; 40(7):974-976. PubMed ID: 32648027
    [No Abstract]   [Full Text] [Related]  

  • 57. Definition and Risks of Cytokine Release Syndrome in 11 Critically Ill COVID-19 Patients With Pneumonia: Analysis of Disease Characteristics.
    Wang W; Liu X; Wu S; Chen S; Li Y; Nong L; Lie P; Huang L; Cheng L; Lin Y; He J
    J Infect Dis; 2020 Oct; 222(9):1444-1451. PubMed ID: 32601708
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical characteristics and outcomes of 2019-nCoV-infected patients admitted at different time periods.
    Liu WR; Zuo GJ; Qin Y
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7826-7833. PubMed ID: 32744710
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rapid identification of SARS-CoV-2-infected patients at the emergency department using routine testing.
    Kurstjens S; van der Horst A; Herpers R; Geerits MWL; Kluiters-de Hingh YCM; Göttgens EL; Blaauw MJT; Thelen MHM; Elisen MGLM; Kusters R
    Clin Chem Lab Med; 2020 Aug; 58(9):1587-1593. PubMed ID: 32598302
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term infection of SARS-CoV-2 changed the body's immune status.
    Lin L; Luo S; Qin R; Yang M; Wang X; Yang Q; Zhang Y; Wang Q; Zhu R; Fan H; Wang H; Hu Y; Wang L; Hu D
    Clin Immunol; 2020 Sep; 218():108524. PubMed ID: 32659373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.